MA33214B1 - Compose pyrazole - Google Patents

Compose pyrazole

Info

Publication number
MA33214B1
MA33214B1 MA34275A MA34275A MA33214B1 MA 33214 B1 MA33214 B1 MA 33214B1 MA 34275 A MA34275 A MA 34275A MA 34275 A MA34275 A MA 34275A MA 33214 B1 MA33214 B1 MA 33214B1
Authority
MA
Morocco
Prior art keywords
atom
hydrogen atom
substituted
halogen
substituent
Prior art date
Application number
MA34275A
Other languages
Arabic (ar)
English (en)
Inventor
Haruyuki Nishida
Ikuo Fujimori
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of MA33214B1 publication Critical patent/MA33214B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRÉSENTE INVENTION CONCERNE UN COMPOSÉ AYANT UNE EXCELLENTE ACTIVITÉ INHIBITRICE SUR LA SÉCRÉTION D'UN ACIDE ET PRÉSENTANT ENTRE AUTRES UNE ACTIVITÉ ANTITUMORALE. LA PRÉSENTE INVENTION CONCERNE SPÉCIFIQUEMENT UN COMPOSÉ REPRÉSENTÉ PAR LA FORMULE (1) [DANS LAQUELLE R1 REPRÉSENTE UN SUBSTITUANT; R2 REPRÉSENTE UN ATOME D'HYDROGÈNE, UN GROUPE ALKYLE EN C1 À C6 QUI PEUT ÊTRE SUBSTITUÉ PAR UN ATOME D'HALOGÈNE, OU UN GROUPE CYANO; ET R3 REPRÉSENTE UN ATOME D'HYDROGÈNE, UN ATOME D'HALOGÈNE, UN GROUPE CYANO, UN GROUPE ALKYLE EN C1 À C6 QUI PEUT ÊTRE SUBSTITUÉ PAR UN ATOME D'HALOGÈNE, UN GROUPE ALCOXY EN C1 À C6 QUI PEUT ÊTRE SUBSTITUÉ PAR UN ATOME D'HALOGÈNE; L'UN DES R2 ET R3 REPRÉSENTANT UN ATOME D'HYDROGÈNE ET L'AUTRE REPRÉSENTANT UN SUBSTITUANT AUTRE QU'UN ATOME D'HYDROGÈNE] OU UN SEL DE CELUI-CI.
MA34275A 2009-03-26 2010-03-25 Compose pyrazole MA33214B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009077078 2009-03-26
PCT/JP2010/055257 WO2010110378A1 (fr) 2009-03-26 2010-03-25 Composé pyrazole

Publications (1)

Publication Number Publication Date
MA33214B1 true MA33214B1 (fr) 2012-04-02

Family

ID=42781069

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34275A MA33214B1 (fr) 2009-03-26 2010-03-25 Compose pyrazole

Country Status (25)

Country Link
US (1) US8895588B2 (fr)
EP (1) EP2412713B1 (fr)
JP (1) JP5552481B2 (fr)
KR (1) KR101656906B1 (fr)
CN (1) CN102448953B (fr)
AU (1) AU2010228220B2 (fr)
BR (1) BRPI1009090A2 (fr)
CA (1) CA2756086A1 (fr)
CL (1) CL2011002351A1 (fr)
CO (1) CO6460700A2 (fr)
CR (1) CR20110533A (fr)
DO (1) DOP2011000296A (fr)
EA (1) EA019853B1 (fr)
EC (1) ECSP11011419A (fr)
GE (1) GEP20156222B (fr)
IL (1) IL215235A (fr)
MA (1) MA33214B1 (fr)
MX (1) MX2011009943A (fr)
NZ (1) NZ595890A (fr)
PE (1) PE20120618A1 (fr)
SG (1) SG174476A1 (fr)
TN (1) TN2011000474A1 (fr)
UA (1) UA107457C2 (fr)
WO (1) WO2010110378A1 (fr)
ZA (1) ZA201107435B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR091567A1 (es) 2012-06-27 2015-02-11 Takeda Pharmaceutical Preparacion liquida, metodo, kit de inyeccion
TWI732158B (zh) 2012-09-27 2021-07-01 美商雅瑞塔那醫療公司 使用食慾喪失控制化合物之組合物及方法
ES2902795T3 (es) 2015-01-28 2022-03-29 Elanco Animal Health Incorporated Composición para uso crónico como compuesto para aumentar de peso
CN105067814A (zh) * 2015-07-24 2015-11-18 中国科学院成都生物研究所 解旋酶水解atp活性测定方法
MX2022016515A (es) * 2020-06-17 2023-01-30 Ildong Pharmaceutical Co Ltd Nuevo inhibidor de la secrecion de acido y uso del mismo.

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3285991A (en) 1963-03-26 1966-11-15 Union Carbide Corp Polyepoxides cured with the reaction product of a dihydroxydiphenylsul-fone, an amine, and an aldehyde
US4847289A (en) 1987-06-08 1989-07-11 Merck & Co., Inc. Thiophene sulfonamide antiglaucoma agents
CN1071924A (zh) 1991-10-29 1993-05-12 纳幕尔杜邦公司 除草的三唑羧酸酰胺
RU2157368C2 (ru) 1994-09-26 2000-10-10 Сионоги Энд Ко., Лтд. Производные имидазола и фармацевтическая композиция на их основе
JPH0948778A (ja) 1995-08-04 1997-02-18 Sagami Chem Res Center 2−置換−3−アルコキシ−5−(ピロール−2−イル)フラン誘導体
JP4533466B2 (ja) 1995-11-06 2010-09-01 ユニバーシティ オブ ピッツバーグ 蛋白質イソプレニルトランスフェラーゼの阻害剤
CN1246847A (zh) 1996-12-23 2000-03-08 杜邦药品公司 作为Xa因子抑制剂的含氮杂芳族化合物
WO1999042461A1 (fr) 1998-02-23 1999-08-26 Warner-Lambert Company Derives de quinoxaline substitues utilises comme antagonistes du recepteur de l'interleukine-8
WO2004012659A2 (fr) 2002-08-01 2004-02-12 Nitromed, Inc. Inhibiteurs nitroses de la pompe a protons, compositions et procedes d'utilisation
ATE410161T1 (de) 2003-05-02 2008-10-15 Elan Pharm Inc 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazol-3- carbonsäureamid-derivate und verwandte verbindungen als bradykinin b1 rezeptor antagonisten zur behandlung von entzündlichen erkrankungen
JP4716996B2 (ja) 2003-05-26 2011-07-06 武田薬品工業株式会社 スルホピロール
JP4836788B2 (ja) 2003-07-23 2011-12-14 エグゼリクシス, インコーポレイテッド 未分化リンパ腫キナーゼ変調因子及びその使用法
WO2006036024A1 (fr) 2004-09-30 2006-04-06 Takeda Pharmaceutical Company Limited Inhibiteurs de pompe a protons
AU2006285641A1 (en) * 2005-08-30 2007-03-08 Takeda Pharmaceutical Company Limited 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
WO2007114338A1 (fr) * 2006-03-31 2007-10-11 Takeda Pharmaceutical Company Limited Inhibiteur de secretion d'acide
US8933105B2 (en) * 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
JP2009077078A (ja) 2007-09-19 2009-04-09 Brother Ind Ltd 位置検出システム
WO2009041705A2 (fr) * 2007-09-28 2009-04-02 Takeda Pharmaceutical Company Limited Composé hétérocyclique à 5 chaînons
WO2009041447A1 (fr) 2007-09-28 2009-04-02 Takeda Pharmaceutical Company Limited Composé hétérocyclique à 5 chaînons
PE20091846A1 (es) 2008-05-19 2009-12-16 Plexxikon Inc DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
KR20110036044A (ko) 2008-07-18 2011-04-06 다케다 파머수티컬 컴패니 리미티드 벤즈아제핀 유도체들 및 히스타민 h3 길항제로서 이들의 용도

Also Published As

Publication number Publication date
UA107457C2 (uk) 2015-01-12
SG174476A1 (en) 2011-10-28
EP2412713B1 (fr) 2016-11-30
NZ595890A (en) 2013-09-27
AU2010228220B2 (en) 2015-05-21
CN102448953A (zh) 2012-05-09
US20120095057A1 (en) 2012-04-19
PE20120618A1 (es) 2012-06-05
CL2011002351A1 (es) 2012-07-13
US8895588B2 (en) 2014-11-25
GEP20156222B (en) 2015-01-26
DOP2011000296A (es) 2011-10-15
BRPI1009090A2 (pt) 2016-03-01
JP5552481B2 (ja) 2014-07-16
CA2756086A1 (fr) 2010-09-30
AU2010228220A1 (en) 2011-11-17
JPWO2010110378A1 (ja) 2012-10-04
MX2011009943A (es) 2011-10-06
EP2412713A4 (fr) 2014-04-02
TN2011000474A1 (en) 2013-03-27
IL215235A (en) 2014-07-31
WO2010110378A1 (fr) 2010-09-30
AU2010228220A2 (en) 2011-11-24
EA201171168A1 (ru) 2012-05-30
ECSP11011419A (es) 2011-11-30
EA019853B1 (ru) 2014-06-30
CR20110533A (es) 2012-02-13
EP2412713A1 (fr) 2012-02-01
ZA201107435B (en) 2012-08-29
KR20110130483A (ko) 2011-12-05
KR101656906B1 (ko) 2016-09-12
CO6460700A2 (es) 2012-06-15
CN102448953B (zh) 2014-05-07
IL215235A0 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
MA33072B1 (fr) Composes pyridazinone
MA32911B1 (fr) Derives de benzothiazole convenant comme agents agents anticancereux
MA31759B1 (fr) Compose amide
MA38540A1 (fr) Dérivés de naphtyridine utiles comme antagonistes de l'intégrine alpha-v-bêta-6
MA31574B1 (fr) Dérivés de pyrazole et leur utilisation comme inhibiteurs de raf
MA31785B1 (fr) Nouveaux dérivés d'imidazole
MA37519B1 (fr) Composés et compositions pour inhiber l'activité d'abl1, abl2 et bcr-abl1
MA34669B1 (fr) Photostabilisants a base d'amines affichant un encombrement sterique a fonctionnalisation mixte
MA33214B1 (fr) Compose pyrazole
MA34551B1 (fr) Agent de lutte contre des organismes nuisibles
MA33519B1 (fr) Hétérocycles microbicides
MA31690B1 (fr) Nouveaux fongicides
MA30984B1 (fr) Compositions pesticides
MA33851B1 (fr) Compose heterocyclique contenant de l'azote et fongicide agricole
MA35639B1 (fr) Compose heterocyclique aromatique dihydroxy
WO2009018909A3 (fr) Dérivés d'alcools alkyliques de 1-phényl-2-pyridinyle en tant qu'inhibiteurs de la phosphodiestérase
MA29141B1 (fr) Pyrrolopyrazoles, servant de puissants inhibiteurs de kinases
MA39172A1 (fr) Dérivés bicycliques hétérocycliques comme inhibiteurs de bromodomaines
MA29323B1 (fr) Composes de l'acide pyridylacetique
MA31444B1 (fr) Agents de lutte contre les parasites invertebres
MA37866B1 (fr) Dérivés de type aza-indazole ou diaza-indazole pour le traitement de la douleur
MA30589B1 (fr) Azolylmethyloxirannes, leur utilisation pour la maitrise de champignons phytopathogenes, ainsi que produits les contenant.
MA31596B1 (fr) Nouveaux herbicides
MA38935B1 (fr) Dérivés de diazacarbazole à titre de ligands tau-pet
MA32985B1 (fr) Nouveaux microbiocides